As of September 2024 Theravance Biopharma has a market cap of A$0.58 Billion. This makes Theravance Biopharma the world's 6880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 20th, 2024 the market cap of Theravance Biopharma was reported to be: